Form 10-K COLUMBIA LABORATORIES For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Columbia Laboratories (CBRX) Misses Q4 EPS by 12c
March 18, 2015 7:07 AM EDTColumbia Laboratories (NASDAQ: CBRX) reported Q4 EPS of ($0.05), $0.12 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $7.3 million versus the consensus estimate of $7.93 million.
Columbia is actively moving forward as a women's health specialty pharmaceutical company focused on 505(b)2... More
